Combined chemotherapy and immunotherapy shows promise for advanced prostate cancers
Wednesday, April 29, 2015 - 14:00
in Health & Medicine
Blocking or removing immune-suppressing cells allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors, researchers report. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer.